Product Introduction
Valgan is a highly effective antiviral medication developed to treat cytomegalovirus (CMV) infections, particularly in individuals with compromised immune systems. With Valganciclovir as its active ingredient, Valgan has proven to be an essential component in managing CMV-related diseases, preventing further complications, and improving patient outcomes.
This medication is commonly prescribed for patients with HIV/AIDS, organ transplant recipients, or those undergoing treatments that compromise their immune function. Valgan plays a critical role in preventing and treating CMV retinitis, a leading cause of blindness among individuals with HIV.
Uses of Valgan
Valgan is primarily used for:

- CMV Retinitis Treatment – Prevents and treats CMV-related eye infections in immunocompromised patients.
- Prevention of CMV in Organ Transplant – Reduces the risk of CMV infection in transplant patients.
- HIV/AIDS Patients – Used to manage CMV infections in individuals living with HIV.
Valgan supports long-term health management in patients at risk for or suffering from CMV infections, offering a proactive approach to viral suppression.
Side Effects of Valgan
Common side effects of Valgan may include:
- Headache
- Nausea
- Fatigue
- Diarrhea
- Vomiting
Less Common Side Effects
Less frequent but more serious side effects may include:
- Bone marrow suppression
- Liver dysfunction
- Anemia
- Renal impairment
We are pleased to offer you this product.
Valgan is a trusted medication for the treatment and prevention of CMV infections, offering an essential solution for individuals with weakened immune systems. Always use Valgan as directed by a healthcare provider for optimal results.
- Take as directed by your healthcare provider, usually once or twice a day with food.
- Complete the full course of treatment as prescribed, even if you feel better.
- Regular blood tests are recommended to monitor liver and kidney function during treatment.
Valgan is a prodrug of ganciclovir. It inhibits the replication of CMV by interfering with the viral DNA polymerase, thus preventing viral replication in infected cells.
- Highly effective in preventing and treating CMV infections.
- Convenient oral formulation.
- Proven track record of safety and efficacy.
- Suitable for long-term use in immunocompromised patients.
- Monitor renal function and complete blood count regularly.
- Do not skip doses to ensure viral suppression.
- Avoid use in patients with a history of severe allergic reactions to ganciclovir or valganciclovir.